Nintx, a biotech startup aiming at generating multi-target therapies based on the Brazilian biodiversity, secures US$ 3 million seed investment
- Nintx
- Aug 22, 2022
- 1 min read
Updated: Mar 14
The seed round, led by deep tech venture capital firm Pitanga, also had the participation of Guilherme Leal (Natura) and Peter Andersen (Grupo Centroflora)

Nintx, a biotech startup aiming at generating multi-target therapies based on the Brazilian biodiversity, secures US$ 3 million seed investment. The seed round, led by deep tech venture capital firm Pitanga, also had the participation of Guilherme Leal (Natura) and Peter Andersen (Grupo Centroflora).
To have access to the full content, check us out on LinkedIn. https://www.linkedin.com/posts/nintx_nintx-a-biotech-startup-aiming-at-generating-activity-6960940559444111360-kUR3/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAUL6oB6dOVqNQ7Ria1q2TMTlnb4Jf7Jwk